Literature DB >> 15509864

The AMP-activated protein kinase pathway--new players upstream and downstream.

D Grahame Hardie1.   

Abstract

The AMP-activated protein kinase (AMPK) cascade is a sensor of cellular energy status. Whenever the cellular ATP:ADP ratio falls, owing to a stress that inhibits ATP production or increases ATP consumption, this is amplified by adenylate kinase into a much larger increase in the AMP:ATP ratio. AMP activates the system by binding to two tandem domains on the gamma subunits of AMPK, and this is antagonized by high concentrations of ATP. AMP binding causes activation by a sensitive mechanism involving phosphorylation of AMPK by the tumour suppressor LKB1. Once activated, AMPK switches on catabolic pathways that generate ATP while switching off ATP-consuming processes. As well as acting at the level of the individual cell, the system also regulates food intake and energy expenditure at the whole body level, in particular by mediating the effects of hormones and cytokines such as leptin, adiponectin and ghrelin. A particularly interesting downstream target recently identified is TSC2 (tuberin). The LKB1-->AMPK-->TSC2 pathway negatively regulates the target of rapamycin (TOR), and this appears to be responsible for limiting protein synthesis and cell growth, and protecting against apoptosis, during cellular stresses such as glucose starvation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509864     DOI: 10.1242/jcs.01540

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  377 in total

1.  The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines.

Authors:  Manuela Lemoine; Enrico Derenzini; Daniela Buglio; L Jeffrey Medeiros; R Eric Davis; Jiexin Zhang; Yuan Ji; Anas Younes
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

2.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.

Authors:  Taj D King; Ling Song; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2006-03-10       Impact factor: 5.858

Review 3.  The role of p53 in cell metabolism.

Authors:  Xing-ding Zhang; Zheng-hong Qin; Jin Wang
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

4.  Prolyl isomerase Pin1 negatively regulates AMP-activated protein kinase (AMPK) by associating with the CBS domain in the γ subunit.

Authors:  Yusuke Nakatsu; Misaki Iwashita; Hideyuki Sakoda; Hiraku Ono; Kengo Nagata; Yasuka Matsunaga; Toshiaki Fukushima; Midori Fujishiro; Akifumi Kushiyama; Hideaki Kamata; Shin-Ichiro Takahashi; Hideki Katagiri; Hiroaki Honda; Hiroshi Kiyonari; Takafumi Uchida; Tomoichiro Asano
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

5.  Age-Dependent Changes in AMPK Metabolic Pathways in the Lung in a Mouse Model of Hemorrhagic Shock.

Authors:  Lindsey R Klingbeil; Paul Kim; Giovanna Piraino; Michael O'Connor; Paul W Hake; Vivian Wolfe; Basilia Zingarelli
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

6.  1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.

Authors:  Rakesh Kumar Sharma; Eduardo Candelario-Jalil; Doris Feineis; Gerhard Bringmann; Bernd L Fiebich; Ravi Shankar Akundi
Journal:  Neurotox Res       Date:  2017-07-18       Impact factor: 3.911

7.  Sepsis and AMPK Activation by AICAR Differentially Regulate FoxO-1, -3 and -4 mRNA in Striated Muscle.

Authors:  Gerald J Nystrom; Charles H Lang
Journal:  Int J Clin Exp Med       Date:  2008-01-20

Review 8.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

9.  Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.

Authors:  Jingtao Luo; Yun Hong; Yang Lu; Songbo Qiu; Bharat K R Chaganty; Lun Zhang; Xudong Wang; Qiang Li; Zhen Fan
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

10.  CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.

Authors:  Hernan Roca; Zachary S Varsos; Kenneth J Pienta
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.